refractory NSCLC

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer . relapsed refractory AML . refractory anemia . rituximab refractory follicular . refractory rituximab naive . refractory multiple myeloma / : IIIB NSCLC . IIIA NSCLC . non squamous NSCLC . metastatic NSCLC . IV NSCLC . NSCLC tumors . recurrent NSCLC * *

Related by context. Frequent words. (Click for all words.) 72 relapsed refractory multiple myeloma 71 docetaxel chemotherapy 71 mRCC 69 metastatic renal cell carcinoma 69 superficial bladder cancer 69 plus dexamethasone 69 relapsed multiple myeloma 69 refractory multiple myeloma 68 heavily pretreated 68 dacarbazine 68 leukemia CLL 68 R sorafenib tablets 67 advanced carcinoid 67 nab paclitaxel 67 Voreloxin 67 primary hypercholesterolemia 67 Pegasys ® 67 unresectable 67 chlorambucil 67 HER2 positive metastatic breast 66 vinorelbine 66 FOLFIRI 66 daunorubicin 66 bendamustine 66 PREZISTA r 66 multiple myeloma MM 66 plus gemcitabine 66 Navelbine 65 Gemzar ® 65 lymphoma CTCL 65 indolent NHL 65 azacitidine 65 Dasatinib 65 resectable 65 cytogenetic response 65 plus prednisone 65 tumor lysis syndrome 65 Epratuzumab 65 fluorouracil 65 hypercalcemia 65 Fludara 65 forodesine 65 Irinotecan 65 HGS ETR1 64 relapsing multiple sclerosis 64 Acute Myeloid Leukemia AML 64 phase IIb clinical 64 Eltrombopag 64 etoposide 64 TACE 64 imatinib mesylate 64 limiting toxicity 64 carboplatin paclitaxel 64 administered subcutaneously 64 secondary hyperparathyroidism 64 KRAS wild 64 refractory Hodgkin lymphoma 64 randomized #:# 64 vandetanib 64 5FU 64 heavily pretreated patients 63 proteasome inhibitor 63 Amrubicin 63 dose limiting toxicities 63 luteinizing hormone releasing 63 voriconazole 63 metastatic castration resistant 63 NYHA Class II 63 Capecitabine 63 Relapsed 63 Pivotal Phase III 63 mg QD 63 gastrointestinal stromal tumors GIST 63 plus ribavirin 63 PEG SN# 63 colorectal carcinoma 63 neoadjuvant 63 Pivotal Phase 63 pertuzumab 63 SHPT 63 decitabine 63 mycophenolate mofetil 63 relapsed refractory 63 advanced NSCLC 63 painful diabetic neuropathy 63 carcinoid tumors 63 IV metastatic melanoma 63 metastatic hormone refractory 63 Lenalidomide 63 cutaneous T cell 63 acute promyelocytic leukemia APL 63 temsirolimus 63 hypomagnesemia 63 interferon alfa 63 adecatumumab 63 mg kg dose 63 corticosteroid therapy 63 Fibrillex TM 63 Traficet EN 62 events SAEs 62 GSK# [001]

Back to home page